InChI=1S/C24H30N2O2.ClH/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21;/h3-12,22H,2,13-19H2,1H3;1H |
MBGXILHMHYLZJT-UHFFFAOYSA-N |
[Cl-].CCN1CC(CC[NH+]2CCOCC2)C(C1=O)(c1ccccc1)c1ccccc1 |
|
central nervous system stimulant
Any drug that enhances the activity of the central nervous system.
|
|
View more via ChEBI Ontology
4-[2-(1-ethyl-5-oxo-4,4-diphenylpyrrolidin-3-yl)ethyl]morpholin-4-ium chloride
|
(±)-doxapram HCl
|
ChEBI
|
(±)-doxapram hydrochloride (anhydrous)
|
ChEBI
|
1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrochloride
|
ChEBI
|
3,3-diphenyl-1-ethyl-4-(2-morpholinoethyl)-2-pyrrolidinone hydrochloride
|
ChemIDplus
|
doxapram HCl
|
ChemIDplus
|
doxapram hydrochloride
|
ChemIDplus
|
113-07-5
|
CAS Registry Number
|
ChemIDplus
|
4171633
|
Beilstein Registry Number
|
Beilstein
|
|